Medtronic PLC (BSP:MDTC34)
R$ 212.34 5.71 (2.76%) Market Cap: 565.80 Bil Enterprise Value: 652.53 Bil PE Ratio: 26.38 PB Ratio: 2.13 GF Score: 77/100

Medtronic Investor Briefing at NANS Transcript

Jan 15, 2021 / 07:15PM GMT
Release Date Price: R$315.2 (+1.65%)
Ryan Weispfenning
Medtronic plc - VP of IR

Okay. I'm showing 1:15 Central time. So we'll go ahead and get started. Good afternoon, good evening, and good morning, depending on where you're joining us today. I'm Ryan Weispfenning, Vice President and Head of Investor Relations at Medtronic. Thanks for joining us for our virtual briefing to discuss our neuromodulation business and the data that's being released in connection with the North American Neuromodulation Society Virtual meeting. While we're not together today in Orlando, as we were originally planning, I do hope everyone is staying safe during the pandemic and look forward to seeing you all in person, again, (inaudible).

The webcast will last about an hour. We'll start with a brief overview of our neurosciences portfolio given by Brett Wall. And then following that, other members of our [neuromodulation] management team will present.

After the presentation, we'll host a Q&A session, where we'll take questions from the sell-side (inaudible) joining the Zoom platform. The slides that we're presenting today will be available on

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot